PEB - Cash Burn Slows; Coverage Catalysts in Focus

DUNEDIN, New Zealand – Pacific Edge (NZX, ASX: PEB) today reports successful execution of strategic initiatives to focus the company on the development of its advanced cancer diagnostic tests for inclusion in clinical guidelines

Related Keywords

Australia ,New Zealand ,United States ,American ,America ,Kaiser Permanente ,Chris Gallaher ,Mark Green ,Peter Meintjes ,Richard Inder ,American Urological Association ,Board Nomination Committee ,Hotmail ,Yahoo ,Pacific Edge Limited ,Centers For Medicare Medicaid Services ,Nominations Committee ,Medicare Local Coverage Determination ,Pacific Edge ,Executive Dr Peter Meintjes ,Middle East ,Latin America ,Medicaid Services ,Analytical Validity ,Clinical Validity ,Clinical Utility ,Independent Director Mark Green ,Nomination Committee ,Annual Report ,Climate Related Disclosure ,Aotearoa New Zealand Climate ,Grant Gibson ,Chief Financial ,Hedge Limited ,